How much funding has Longboard Pharmaceuticals raised?

Longboard Pharmaceuticals has disclosed $56M raised across 1 round.

Where is Longboard Pharmaceuticals headquartered?

Longboard Pharmaceuticals is headquartered in San Diego, US.

Longboard Pharmaceuticals

San Diego, US · Founded 2020 · Delaware corporation · 19 employees on LinkedIn

Longboard Pharmaceuticals is a clinical-stage biopharmaceutical company developing small-molecule medicines targeting G protein-coupled receptors for neurological diseases, with an initial focus on rare conditions. Its lead candidate, bexicaserin (LP352), is an oral 5-HT2C receptor superagonist in development for seizures associated with developmental and epileptic encephalopathies; the company is now a subsidiary of Lundbeck.

Biotech Healthtech

Founders & leadership

Kevin LindinPresident & CEO

Randall KayeinEVP & Chief Medical Officer

Brandi RobertsinChief Financial Officer

Steven SpectorinGeneral Counsel / Head of Business Development

Chad OrevilloinHead of Clinical Operations

Laurie StelzerNamed on SEC filing

Vincent AurentzNamed on SEC filing

Chandra LeoNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$56M disclosed across 1 round · 2020

▶$56MraisedNov 2020 · 17 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Laurie StelzerDirector
Kevin R LindExecutive Officer, Director
Vincent AurentzDirector
Chandra LeoDirector

Offering amount: $56M
Amount sold: $56M
First sale: Oct 2020
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

LeadIQ8 shared keywordsLeadIQ offers a company search tool that provides B2B company profiles with data such as revenue, employee count, funding, and contact information to help sales teams find decision makers and build pipeline.

Companies competing with Longboard Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Longboard Pharmaceuticals do?: Longboard Pharmaceuticals is a clinical-stage biopharmaceutical company developing small-molecule medicines targeting G protein-coupled receptors for neurological diseases, with an initial focus on rare conditions. Its lead candidate, bexicaserin (LP352), is an oral 5-HT2C receptor superagonist in development for seizures associated with developmental and epileptic encephalopathies; the company is now a subsidiary of Lundbeck.
How much funding has Longboard Pharmaceuticals raised?: Longboard Pharmaceuticals has disclosed $56M raised across 1 round.
Where is Longboard Pharmaceuticals headquartered?: Longboard Pharmaceuticals is headquartered in San Diego, US.